Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 4,000
- 试验地点
- 63
- 主要终点
- Adherence to ESC Guidelines in Heart Failure 2021
研究概览
简要总结
The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country.
Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.
详细描述
Information collected by the GRASP-HF study assesses adherence to the ESC HF Guidelines focusing on Quality Indicators, in both chronic and acute HF.
For that reason, the GRASP-HF snapshot study is evolving in parallel with the long-term Heart Failure Association initiative - ICARe-HF: the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. ICARe-HF is an international accreditation programme for heart failure centres which is about improving patient outcomes by raising standards in care facilities and recognising those that apply best practices. The GRASP-HF snapshot study serves to verify the performance of individual centres through data collection of real-world patient data.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either:
- •Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment.
- •Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.
排除标准
- •Age <18 years
- •Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).
结局指标
主要结局
Adherence to ESC Guidelines in Heart Failure 2021
时间窗: 12 months per site
Full adherence to guidelines for heart failure management
次要结局
未报告次要终点